{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:35:06Z","timestamp":1778621706773,"version":"3.51.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1007\/s11940-006-0015-9","type":"journal-article","created":{"date-parts":[[2007,6,5]],"date-time":"2007-06-05T20:17:51Z","timestamp":1181074671000},"page":"245-255","source":"Crossref","is-referenced-by-count":10,"title":["The diagnosis and treatment of depression in parkinson\u2019s disease"],"prefix":"10.1007","volume":"8","author":[{"given":"William M.","family":"McDonald","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul E.","family":"Holtzheimer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eve H.","family":"Byrd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"15_CR1","first-page":"333","volume-title":"The Physician\u2019s Guide to Depression and Bipolar Disorders","author":"PE Holtzheimer","year":"2005","unstructured":"Holtzheimer PE, McDonald WM, DeLong MR: Mood disorders in Parkinson\u2019s disease. In The Physician\u2019s Guide to Depression and Bipolar Disorders. Edited by Evans D, Charney DS. New York: McGraw-Hill; 2005:333\u2013354. Provides a more comprehensive review of the epidemiology, etiology, and treatment of dPD."},{"key":"15_CR2","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1159\/000071195","volume":"22","author":"AF Leentjens","year":"2003","unstructured":"Leentjens AF, Van den Akker M, Metsemakers JF, et al.: The incidence of Parkinson\u2019s disease in the Netherlands: results from a longitudinal general practice-based registration. Neuroepidemiology 2003, 22:311\u2013312.","journal-title":"Neuroepidemiology"},{"key":"15_CR3","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S1353-8020(03)00067-1","volume":"10","author":"A Rojo","year":"2003","unstructured":"Rojo A, Aguilar M, Garolera MT, et al.: Depression in Parkinson\u2019s disease: clinical correlates and outcome. Parkinsonism Relat Disord 2003, 10:23\u201328.","journal-title":"Parkinsonism Relat Disord"},{"key":"15_CR4","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/BF01271246","volume":"103","author":"W Kuhn","year":"1996","unstructured":"Kuhn W, Heye N, Muller T, et al.: The motor performance test series in Parkinson\u2019s disease is influenced by depression. J Neural Transm 1996, 103:349\u2013354.","journal-title":"J Neural Transm"},{"key":"15_CR5","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1093\/brain\/112.5.1141","volume":"112","author":"SE Starkstein","year":"1989","unstructured":"Starkstein SE, Preziosi TJ, Berthier ML, et al.: Depression and cognitive impairment in Parkinson\u2019s disease. Brain 1989, 112:1141\u20131153.","journal-title":"Brain"},{"key":"15_CR6","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/1531-8257(200003)15:2<216::AID-MDS1003>3.0.CO;2-#","volume":"15","author":"AM Kuopio","year":"2000","unstructured":"Kuopio AM, Marttila RJ, Helenius H, et al.: The quality of life in Parkinson\u2019s disease. Mov Disord 2000, 15:216\u2013223.","journal-title":"Mov Disord"},{"key":"15_CR7","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/BF03324464","volume":"14","author":"M Caap-Ahlgren","year":"2002","unstructured":"Caap-Ahlgren M, Dehlin O: Factors of importance to the caregiver burden experienced by family caregivers of Parkinson\u2019s disease patients. Aging Clin Exp Res 2002, 14:371\u2013377.","journal-title":"Aging Clin Exp Res"},{"key":"15_CR8","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1177\/0891988703256053","volume":"16","author":"D Weintraub","year":"2003","unstructured":"Weintraub D, Moberg PJ, Duda JE, et al.: Recognition and treatment of depression in Parkinson\u2019s disease. J Geriatr Psychiatry Neurol 2003, 16:178\u2013183.","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"15_CR9","doi-asserted-by":"crossref","unstructured":"Marsh L, McDonald WM, Cummings JL, et al.: Provisional diagnostic criteria for depression in Parkinson\u2019s disease: report of an NINDS\/NIMH work group. Mov Disord 2006, In press.","DOI":"10.1002\/mds.20723"},{"key":"15_CR10","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/S0006-3223(03)00530-4","volume":"54","author":"WM McDonald","year":"2003","unstructured":"McDonald WM, Richard IH, DeLong MR: Prevalence, etiology, and treatment of depression in Parkinson\u2019s disease. Biol Psychiatry 2003, 54:363\u2013375.","journal-title":"Biol Psychiatry"},{"key":"15_CR11","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/mds.10041","volume":"17","author":"V Isella","year":"2002","unstructured":"Isella V, Melzi P, Grimaldi M, et al.: Clinical, neuropsychological, and morphometric correlates of apathy in Parkinson\u2019s disease. Mov Disord 2002, 17:366\u2013371.","journal-title":"Mov Disord"},{"key":"15_CR12","doi-asserted-by":"crossref","unstructured":"Weintraub D, Oehlberg KA, Katz IR, et al.: Test characteristics of the 15-item Geriatric Depression Scale and Hamilton Depression Rating Scale in Parkinson\u2019s disease. Am J Geriatr Psychiatry 2006, In press.","DOI":"10.1097\/01.JGP.0000192488.66049.4b"},{"key":"15_CR13","doi-asserted-by":"crossref","unstructured":"McDonald WM, Holtzheimer PE, Haber M, et al.: Validity of the 30-item Geriatric Depression Scale in patients with Parkinson\u2019s disease. Mov Disord 2006, In press.","DOI":"10.1002\/mds.21023"},{"key":"15_CR14","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S1353-8020(01)00015-3","volume":"8","author":"LM Shulman","year":"2002","unstructured":"Shulman LM, Taback RL, Rabinstein AA, et al.: Non-recognition of depression and other non-motor symptoms in Parkinson\u2019s disease. Parkinsonism Relat Disord 2002, 8:193\u2013197.","journal-title":"Parkinsonism Relat Disord"},{"key":"15_CR15","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1097\/01.jcp.0000088908.24613.db","volume":"23","author":"A Avila","year":"2003","unstructured":"Avila A, Cardona X, Martin-Baranera M, et al.: Does nefazodone improve both depression and Parkinson disease? A pilot randomized trial. J Clin Psychopharmacol 2003, 23:509\u2013513.","journal-title":"J Clin Psychopharmacol"},{"key":"15_CR16","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1176\/jnp.14.3.329","volume":"14","author":"P Naarding","year":"2002","unstructured":"Naarding P, Leentjens AF, van Kooten F, et al.: Diseasespecific properties of the Rating Scale for Depression in patients with stroke, Alzheimer\u2019s dementia, and Parkinson\u2019s disease. J Neuropsychiatry Clin Neurosci 2002, 14:329\u2013334.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"15_CR17","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/gps.865","volume":"18","author":"AF Leentjens","year":"2003","unstructured":"Leentjens AF, Vreeling FW, Luijckx GJ, et al.: SSRIs in the treatment of depression in Parkinson\u2019s disease. Int J Geriatr Psychiatry 2003, 18:552\u2013554.","journal-title":"Int J Geriatr Psychiatry"},{"key":"15_CR18","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1002\/gps.465","volume":"16","author":"BH Mulsant","year":"2001","unstructured":"MulsantBH, Alexopoulos GS, Reynolds 3rd CF, et al.: Pharmacological treatment of depression in older primary care patients: the PROSPECT algorithm. Int J Geriatr Psychiatry 2001, 16:585\u2013592. Provides a data-based treatment algorithm for depression that is designed for primary care practitioners and other nonpsychiatrists. This algorithm forms the basis for the treatment approach we use for dPD in our clinic.","journal-title":"Int J Geriatr Psychiatry"},{"key":"15_CR19","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1001\/archpsyc.62.4.409","volume":"62","author":"RJ DeRubeis","year":"2005","unstructured":"DeRubeis RJ, Hollon SD, Amsterdam JD, et al.: Cognitive therapy vs medications in the treatment of moderate to severe depression. Arch Gen Psychiatry 2005, 62:409\u2013416.","journal-title":"Arch Gen Psychiatry"},{"key":"15_CR20","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00406-004-0542-x","volume":"255","author":"MF de Mello","year":"2005","unstructured":"de MelloMF, de JesusMari J, Bacaltchuk J, et al.: A systematic review of research findings on the efficacy of interpersonal therapy for depressive disorders. Eur Arch Psychiatry Clin Neurosci 2005, 255:75\u201382.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"15_CR21","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1056\/NEJM200005183422001","volume":"342","author":"MB Keller","year":"2000","unstructured":"Keller MB, McCullough JP, Klein DN, et al.: A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med 2000, 342:1462\u20131470.","journal-title":"N Engl J Med"},{"key":"15_CR22","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s00406-003-0430-9","volume":"253","author":"M Bauer","year":"2003","unstructured":"Bauer M, Forsthoff A, Baethge C, et al.: Lithium augmentation therapy in refractory depression--update 2002. Eur Arch Psychiatry Clin Neurosci 2003, 253:132\u2013139.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"15_CR23","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/S0140-6736(03)12705-5","volume":"361","author":"UK ECT Review Group","year":"2003","unstructured":"UK ECT Review Group: Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet 2003, 361:799\u2013808. Provides an excellent, comprehensive review of data on ECT as a treatment for depression.","journal-title":"Lancet"},{"key":"15_CR24","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1176\/jnp.15.4.407","volume":"15","author":"R Kennedy","year":"2003","unstructured":"Kennedy R, Mittal D, O\u2019Jile J: Electroconvulsive therapy in movement disorders: an update. J Neuropsychiatry Clin Neurosci 2003, 15:407\u2013421.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"15_CR25","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1136\/jnnp.2005.069849","volume":"76","author":"F Fregni","year":"2005","unstructured":"Fregni F, Simon DK, Wu A, et al.: Non-invasive brain stimulation for Parkinson\u2019s disease: a systematic review and meta-analysis of the literature. J Neurol Neurosurg Psychiatry 2005, 76:1614\u20131623.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"15_CR26","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1136\/jnnp.2003.027060","volume":"75","author":"F Fregni","year":"2004","unstructured":"Fregni F, Santos CM, Myczkowski ML, et al.: Repetitive transcranial magnetic stimulation is as effective as fluoxetine in the treatment of depression in patients with Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 2004, 75:1171\u20131174.","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-006-0015-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11940-006-0015-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-006-0015-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-006-0015-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,15]],"date-time":"2022-05-15T11:30:52Z","timestamp":1652614252000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11940-006-0015-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["15"],"URL":"https:\/\/doi.org\/10.1007\/s11940-006-0015-9","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,5]]}}}